Mandolin

Delivery infrastructure for advanced therapies

Mandolin builds the last-mile delivery infrastructure that gets biologics, cell and gene therapies to patients faster. As drug discovery becomes an engineering discipline and nearly all disease moves toward being treatable, the constraint shifts from whether a therapy exists to whether a specific patient can actually receive it — a problem of coordination, authorisation and administration rather than science. Its AI-powered knowledge-worker platform already serves leading infusion clinics, with payers and pharmaceutical companies next. It is backed by Greylock, SignalFire and Maverick.